| Literature DB >> 2340853 |
N Inotsume1, M Nishimura, M Nakano, S Fujiyama, K Sagara, T Sato, K Matsushita, Y Imai, H Matsui.
Abstract
The effect of haemodialysis on the pharmacokinetics of oral famotidine has been studied in five elderly anuric patients. Famotidine 20 mg was administered in a cross-over design to patients on and not on haemodialysis. The elimination rate constant of haemodialysis (k) was 4.6-fold larger than the systemic elimination rate constant (ke). Although the mean maximum serum concentration of famotidine during haemodialysis (141.5 ng.ml-1) was not significantly lower than that without haemodialysis (195.6 ng.ml-1), the AUC up to 5 h during haemodialysis was significantly decreased to 58.1% of the value without it. The data suggest that famotidine is dialysable by haemodialysis.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2340853 DOI: 10.1007/bf00315039
Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN: 0031-6970 Impact factor: 2.953